Familial amyloidosis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
Familiar amyloidosis may be classified according to the type of mutant protein into 6 subtypes:<ref name="Benson2003">{{cite journal|last1=Benson|first1=Merrill D|title=The hereditary amyloidoses|journal=Best Practice & Research Clinical Rheumatology|volume=17|issue=6|year=2003|pages=909–927|issn=15216942|doi=10.1016/j.berh.2003.09.001}}</ref> | Familiar amyloidosis may be classified according to the type of mutant protein into 6 subtypes:<ref name="Benson2003">{{cite journal|last1=Benson|first1=Merrill D|title=The hereditary amyloidoses|journal=Best Practice & Research Clinical Rheumatology|volume=17|issue=6|year=2003|pages=909–927|issn=15216942|doi=10.1016/j.berh.2003.09.001}}</ref> | ||
* | * Transthyretin amyloidosis (TTR) | ||
* | * Apolipoprotein AI | ||
* | * Cystatin C | ||
* | * Lysozyme | ||
* | * Fibrinogen A alpha-chain | ||
* | * Apolipoprotein AII | ||
==References== | ==References== | ||
Revision as of 16:30, 4 November 2019
|
Familial amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Familial amyloidosis classification On the Web |
|
American Roentgen Ray Society Images of Familial amyloidosis classification |
|
Risk calculators and risk factors for Familial amyloidosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Familiar amyloidosis may be classified according to the type of mutant protein into 6 subtypes: Transthyretin amyloidosis (TTR), apolipoprotein AI, cystatin C, lysozyme, fibrinogen A alpha-chain, and apolipoprotein AII.
Classification
Familiar amyloidosis may be classified according to the type of mutant protein into 6 subtypes:[1]
- Transthyretin amyloidosis (TTR)
- Apolipoprotein AI
- Cystatin C
- Lysozyme
- Fibrinogen A alpha-chain
- Apolipoprotein AII
References
- ↑ Benson, Merrill D (2003). "The hereditary amyloidoses". Best Practice & Research Clinical Rheumatology. 17 (6): 909–927. doi:10.1016/j.berh.2003.09.001. ISSN 1521-6942.